-
DE
Gyrase inhibitors are antibiotics that block bacterial enzymes essential for DNA replication, effectively killing bacteria. They are used to treat a wide range of bacterial infections.
Gyrase inhibitors are antibiotics that block bacterial enzymes essential for DNA replication, effectively killing bacteria. They are used to treat a wide range of bacterial infections.
Gyrase inhibitors – also known as fluoroquinolones or quinolones – are a class of antibiotics that interfere with bacterial DNA replication. They inhibit two key bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for controlling the winding and unwinding of bacterial DNA during cell division. Without them, bacteria cannot replicate and ultimately die.
Bacterial DNA exists in a tightly coiled (superhelical) form. DNA gyrase regulates these coils, enabling DNA replication and transcription to proceed. Gyrase inhibitors bind to the enzyme-DNA complex and block its activity, causing double-strand breaks in the bacterial DNA. This leads to bacterial cell death. Because they kill bacteria directly rather than simply halting their growth, gyrase inhibitors are classified as bactericidal agents.
Gyrase inhibitors are prescribed for a wide range of bacterial infections, including:
The most widely used gyrase inhibitors include:
Dosage varies depending on the specific agent, indication, and severity of infection. Gyrase inhibitors are available as tablets, intravenous infusions, and in some cases as eye drops or ear drops. The exact dosage and duration of treatment should always be determined by a healthcare professional. Patients should complete the full course of therapy to prevent the development of antibiotic resistance.
Gyrase inhibitors can cause a range of side effects. Common side effects include:
Rare but serious side effects include:
Due to the potential for serious adverse effects, European and international health authorities recommend using gyrase inhibitors only when no suitable alternative antibiotics are available.
Gyrase inhibitors should not be used in:
Important drug interactions include:
The widespread and sometimes indiscriminate use of gyrase inhibitors has led to a significant increase in antibiotic resistance against this drug class over recent decades. Resistant strains of gram-negative bacteria such as Escherichia coli and Klebsiella pneumoniae are of particular concern. Responsible use in accordance with medical prescription is therefore essential to preserve the effectiveness of these antibiotics.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.